Loading…
Evaluation of [18F]-CP18 as a PET Imaging Tracer for Apoptosis
Purpose We identified and validated [ 18 F]-CP18, a DEVD (the caspase 3 substrate recognition motif) containing substrate-based compound as an imaging tracer for caspase-3 activity in apoptotic cells. Procedures CP18 was radiolabeled with fluorine-18 using click chemistry. The affinity and selectivi...
Saved in:
Published in: | Molecular imaging and biology 2013-12, Vol.15 (6), p.739-747 |
---|---|
Main Authors: | , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Purpose
We identified and validated [
18
F]-CP18, a DEVD (the caspase 3 substrate recognition motif) containing substrate-based compound as an imaging tracer for caspase-3 activity in apoptotic cells.
Procedures
CP18 was radiolabeled with fluorine-18 using click chemistry. The affinity and selectivity of CP18 for caspase-3 were evaluated
in vitro
. The biodistribution and metabolism pattern of [
18
F]-CP18 were assessed
in vivo
. [
18
F]-CP18 positron emission tomography (PET) scans were performed in a dexamethasone-induced thymic apoptosis mouse model. After imaging, the mice were sacrificed, and individual organs were collected, measured in a gamma counter, and tested for caspase-3 activity.
Results
In vitro
enzymatic caspase-3 assay demonstrated specific cleavage of CP18.
In vivo
, [
18
F]-CP18 is predominantly cleared through the kidneys and urine, and is rapidly eliminated from the bloodstream. There was a sixfold increase in caspase activity and a fourfold increase of [
18
F]-CP18 retention in the dexamethasone-induced thymus of treated versus control mice.
Conclusions
We report the use [
18
F]-CP18 as a PET tracer for imaging apoptosis. Our data support further development of this tracer for clinical PET applications. |
---|---|
ISSN: | 1536-1632 1860-2002 |
DOI: | 10.1007/s11307-013-0644-9 |